These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2724893)

  • 1. [Early diagnosis and characteristics of the course of HBsAg-positive and HBsAg-negative chronic persistent hepatitis].
    Dzhumabaev TZ
    Klin Med (Mosk); 1989 Feb; 67(2):73-5. PubMed ID: 2724893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic significance of erythrocyte carbohydrate metabolism indicators in chronic subclinical HBsAG carrier state].
    Levina LD; Bezuglova IA; Proĭdakov MA
    Klin Med (Mosk); 1995; 73(6):26-8. PubMed ID: 8691773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognostic significance of quantitative HBsAG determination in acute hepatitis B].
    Joller-Jemelka HI; Pfister HF; Grob PJ
    Schweiz Med Wochenschr; 1985 Sep; 115(37):1249-56. PubMed ID: 3903984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pattern of distribution of pre S and S coded viral envelope proteins of hepatitis B virus on the molecular level in serum and liver tissue of chronic HBsAg carriers].
    Gerken G; Manns M; Gerlich WH; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
    Verh Dtsch Ges Inn Med; 1989; 95():1-6. PubMed ID: 2603475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic reactivity of the skin in chronic hepatitis].
    Fuchs H
    Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HBsAg carriers--a study performed on a closed collective of 0- to 3-year-old children].
    Moldovan L; Fărcaş G; Grosu M; Birţ M
    Pediatrie (Bucur); 1990; 39(2):157-63. PubMed ID: 1966512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
    Lu P; Wang J; Wu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum concentration of bile acids in HBsAG-positive asymptomatic subjects].
    Marotta F; Morello P; Hashimoto L; Rahman M
    G Clin Med; 1988 Nov; 69(11):657-9. PubMed ID: 3243399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
    Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
    J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns.
    Delaplane D; Yogev R; Crussi F; Shulman ST
    Pediatrics; 1983 Aug; 72(2):176-80. PubMed ID: 6683400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hepatitis B as a factor in the etiology of cataracts in adults and children].
    Kushnir VN; Slepova OS; Zaĭtseva NS; Titarenko ZD; Dumbrava VA; Vovk EM
    Vestn Oftalmol; 1996; 112(1):46-50. PubMed ID: 8659073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency and clinical relevance of delta virus infection in HBsAg carriers in the Berlin area].
    Möller B; Hopf U; Hoffmann H; Alexander M; Lobeck H
    Z Gastroenterol; 1988 Jun; 26(6):314-21. PubMed ID: 3264646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HBsAg in the hepatocytes in chronic liver diseases].
    Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD; Zotina MM
    Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of postacute viral hepatitis: the role of HBsAg.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1986; 24(1):19-22. PubMed ID: 3704499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hepatitis associated with prolonged hemodialysis treatment].
    Kiriakov Z; Patev E; Todorov K; Simeonov P; Dimitrova T
    Vutr Boles; 1982; 21(4):41-6. PubMed ID: 7147918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
    el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
    Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.